NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00265018,HD10 for Early Stages,https://clinicaltrials.gov/study/NCT00265018,,COMPLETED,This study is designed to find the optimum radiation dose and number of cycles for an ABVD chemotherapy combined with an involved field irradiation. It is to be tested whether the reduction from 4 to 2 cycles of ABVD and/or the reduction of the radiation dose from 30 to 20 Gy is feasible without a loss of efficacy.,NO,HodgkinÂ´s Lymphoma,DRUG: Adriamycin|DRUG: Bleomycin|DRUG: Vinblastine|DRUG: DTIC|RADIATION: 30 Gy IF-RT|RADIATION: 20 Gy IF-RT,"Progression free survival (PFS), 5 years",,,University of Cologne,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,1370,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: TREATMENT,HD10,1998-05,2003-01,,2005-12-13,,2011-07-29,,
